Skip to main content

Table 1 The prevalence and relationship of Kras mutations and Her2 amplification in mucinous ovarian carcinoma

From: The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma

 

Her2 non-amplification

Her2 amplification

Total

n (%)

n (%)

n (%)

Kras wild type

3 (14.29)

5 (23.81)

8 (38.10)

Kras mutation

11 (52.38)

2 (9.52)

13 (61.90)

Total

14 (66.67)

7 (33.33)

21 (100.00)

P value

0.056a

  
  1. n (%) number (percentage)
  2. aFisher’s exact test